Category: Interviews
Discussing Crowd Funded Cures with Savva Kerdemelidis
May 17, 2022
We have written extensively about VitaDAO, a collective dedicated to community-governed, decentralized drug development. Probably the fastest and cheapest way to get geroprotective drugs to the market is by repurposing
João Pedro de Magalhães on Reprogramming and Aging Theories
May 13, 2022
Professor João Pedro de Magalhães leads the Genomics of Ageing and Rejuvenation Lab at the Institute of Inflammation and Ageing in the University of Birmingham. He is also CSO of
Prof. Richard Miller on the Interventions Testing Program
May 5, 2022
Richard A. Miller is a Professor of Pathology at the University of Michigan and the Director of Michigan’s Paul F. Glenn Center for Biology of Aging Research. He is also
Yuri Deigin on Cellular Reprogramming in Humans
May 4, 2022
In a recent press release, YouthBio Therapeutics announced that it has left stealth mode. YouthBio is a self-proclaimed longevity biotech company with a focus on developing gene therapies that reverse
Discussing Low-Dose Naltrexone with Sajad Zalzala
April 20, 2022
Dr. Sajad Zalzala, co-founder of AgelessRx, prescribes naltrexone for a variety of conditions and is currently enrolling patients in clinical trials for its effectiveness against the lingering effects of COVID-19
Dr. Steven Austad on Aging in Wild and Lab Animals
April 12, 2022
Dr. Steven Austad of the University of Alabama at Birmingham is not a typical geroscientist, or at least, he did not become one in a typical way. After obtaining his undergraduate
Raiany Romanni on the Ethical Aspects of Life Extension
April 1, 2022
Raiany Romanni is a Harvard Kennedy Fellow in Effective Altruism, an A360 Scholar, a Stanford Existential Risk Fellow, and a bioethicist. She is currently working on a non-fiction book aimed
Dr. Simon Melov on Single Cell Genomics
March 8, 2022
Dr. Simon Melov is a professor at the Buck Institute for Research on Aging. His lab is working on identifying the molecular hallmarks of aging, specifically in the context of
Dr. Pankaj Kapahi: “AGEs are a Trillion-Dollar Industry”
February 22, 2022
Dr. Pankaj Kapahi is a veteran geroscientist. His laboratory at the famous Buck Institute for Research on Aging is among the few that study advanced glycation end products (AGEs) and
Sonia Arrison: “Aging Is One of the Last Unifying Issues”
January 31, 2022
Sonia Arrison is an entrepreneur, investor, and best-selling author. Her book “100 Plus: How the Coming Age of Longevity Will Change Everything”, published in 2011, was one of the first
Dr. Brian Kennedy: From Sickcare to Healthcare
January 14, 2022
Dr. Brian Kennedy is a longevity heavyweight: a former President of the Buck Institute, currently a Distinguished Professor in the Department of Biochemistry and Physiology at the National University of
Tina Woods on a Longevity Ecosystem at EARD2021
December 20, 2021
At Ending Age-Related Diseases 2021, Elena Milova of Lifespan.io interviewed Tina Woods on the development of a longevity ecosystem, the importance of language, and the social aspects of extending lifespans.
Dr. Jean Hébert on Brain Regeneration at EARD2021
November 26, 2021
At Ending Age-Related Diseases 2021, Elena Milova interviewed Dr. Jean Hébert on how the human brain can be restored to youthful function. Script Elena: Greetings to the participants of Ending
Martin Borch Jensen: Cutting the Gordian Knot of Aging
November 23, 2021
Before founding Impetus Grants, a non-profit that aims to speed up longevity research by handing out money to scientists, minus the bureaucracy, Martin Borch Jensen did his doctorate in the
Lorna Harries: “We’re Looking to Reverse Senescence”
November 3, 2021
Lorna Harries is a Professor of Molecular Genetics at the University of Exeter Medical School. She is also the CSO and R&D lead at SENISCA Ltd. Like many other companies,
Discussing Crowd Funded Cures with Savva Kerdemelidis
May 17, 2022
We have written extensively about VitaDAO, a collective dedicated to community-governed, decentralized drug development. Probably the fastest and cheapest way to get geroprotective drugs to the market is by repurposing existing drugs, such as rapamycin, metformin, and acarbose. These drugs cost next to nothing, have a
João Pedro de Magalhães on Reprogramming and Aging Theories
May 13, 2022
Professor João Pedro de Magalhães leads the Genomics of Ageing and Rejuvenation Lab at the Institute of Inflammation and Ageing in the University of Birmingham. He is also CSO of YouthBio Therapeutics, a US-based biotech company that develops rejuvenation gene therapies based on partial reprogramming by
Prof. Richard Miller on the Interventions Testing Program
May 5, 2022
Richard A. Miller is a Professor of Pathology at the University of Michigan and the Director of Michigan’s Paul F. Glenn Center for Biology of Aging Research. He is also a driving force behind the ITP, the Interventions Testing Program, created in the early 2000s to
Yuri Deigin on Cellular Reprogramming in Humans
May 4, 2022
In a recent press release, YouthBio Therapeutics announced that it has left stealth mode. YouthBio is a self-proclaimed longevity biotech company with a focus on developing gene therapies that reverse the epigenetic alterations that cause us to age. The company is hoping to reverse cellular aging
Discussing Low-Dose Naltrexone with Sajad Zalzala
April 20, 2022
Dr. Sajad Zalzala, co-founder of AgelessRx, prescribes naltrexone for a variety of conditions and is currently enrolling patients in clinical trials for its effectiveness against the lingering effects of COVID-19 as well as for longevity. We caught up with him to discuss the progress in this
Dr. Steven Austad on Aging in Wild and Lab Animals
April 12, 2022
Dr. Steven Austad of the University of Alabama at Birmingham is not a typical geroscientist, or at least, he did not become one in a typical way. After obtaining his undergraduate degree in English literature, Steven spent several years on jobs such as a wild animal trainer
Raiany Romanni on the Ethical Aspects of Life Extension
April 1, 2022
Raiany Romanni is a Harvard Kennedy Fellow in Effective Altruism, an A360 Scholar, a Stanford Existential Risk Fellow, and a bioethicist. She is currently working on a non-fiction book aimed at catalyzing the ethics of longevity research, while suggesting that aging is the costliest of all
Dr. Simon Melov on Single Cell Genomics
March 8, 2022
Dr. Simon Melov is a professor at the Buck Institute for Research on Aging. His lab is working on identifying the molecular hallmarks of aging, specifically in the context of cellular senescence. Recently, the lab published a paper in which it announced a discovery of a
Dr. Pankaj Kapahi: “AGEs are a Trillion-Dollar Industry”
February 22, 2022
Dr. Pankaj Kapahi is a veteran geroscientist. His laboratory at the famous Buck Institute for Research on Aging is among the few that study advanced glycation end products (AGEs) and the many ways in which they affect aging. Dr. Kapahi’s company, Juvify, produces GLYLO, a supplement
Sonia Arrison: “Aging Is One of the Last Unifying Issues”
January 31, 2022
Sonia Arrison is an entrepreneur, investor, and best-selling author. Her book “100 Plus: How the Coming Age of Longevity Will Change Everything”, published in 2011, was one of the first to bring the topic of longevity to the general public’s attention. Sonia is also founder of
Dr. Brian Kennedy: From Sickcare to Healthcare
January 14, 2022
Dr. Brian Kennedy is a longevity heavyweight: a former President of the Buck Institute, currently a Distinguished Professor in the Department of Biochemistry and Physiology at the National University of Singapore, a co-editor of Aging Cell, and one of the researchers behind a recent study of
Tina Woods on a Longevity Ecosystem at EARD2021
December 20, 2021
At Ending Age-Related Diseases 2021, Elena Milova of Lifespan.io interviewed Tina Woods on the development of a longevity ecosystem, the importance of language, and the social aspects of extending lifespans. Script Elena: Greetings to the participants of Ending Age-Related Diseases 2021. This conference brings together thought
Dr. Jean Hébert on Brain Regeneration at EARD2021
November 26, 2021
At Ending Age-Related Diseases 2021, Elena Milova interviewed Dr. Jean Hébert on how the human brain can be restored to youthful function. Script Elena: Greetings to the participants of Ending Age-Related Diseases 2021. This conference brings together thought leaders and researchers working on rejuvenation biotechnology with
Martin Borch Jensen: Cutting the Gordian Knot of Aging
November 23, 2021
Before founding Impetus Grants, a non-profit that aims to speed up longevity research by handing out money to scientists, minus the bureaucracy, Martin Borch Jensen did his doctorate in the Bohr lab at the NIA and his postdoc at the Buck Institute, and he received an
Lorna Harries: “We’re Looking to Reverse Senescence”
November 3, 2021
Lorna Harries is a Professor of Molecular Genetics at the University of Exeter Medical School. She is also the CSO and R&D lead at SENISCA Ltd. Like many other companies, and as evidenced by the name, SENISCA targets senescent cells, albeit using an unusual mRNA-based approach.